INGLIS TIFFANY EUL DAVIS (Chief Medical Officer) sold 0.4% of their position (362.00 shares) of SERA PROGNOSTICS, INC. on the open market
Open‑market sale worth $727.62 — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/15/2026ACC: 0002091798-26-000004
Officer· Chief Medical Officer
Since Mar 2026
-362.00
Net shares
Net seller
$727.62
Total sold
1
Open market trades
0B · 1S
1
Total transactions
362.00 disposed
Non-Derivative Transactions1
Class A Common Stock
Direct
Shares
−362.00
Price / share
$2.01
Trade value
$727.62
% of position
0.4%
6/11/2026
92.44K→92.08K
Total
Net shares
−362.00
Net value
-$727.62
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 6/11/2026 | S · Sale | −362.00 | $2.01 | $727.62 | 0.4% | 92.44K | 92.08K |
| Total | −362.00 | -$727.62 | ||||||
Derivative Transactions0
No derivative transactions reported